We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

عن Hemangioma Disease

ورم وعائي هو واحد من الأورام الحميدة شيوعا من سن الطفولة.

A hemangioma, also known as infantile hemangioma (IH), is one of the most common benign tumors of infancy and occurs in approximately 5–10% of infants, though it occurs past infancy on rare occasions. Infantile hemangiomas are benign vascular tumors composed of an increased number of unique endothelial cells that line blood vessels. They occur more frequently in female, premature and low birth weight infants. Infantile hemangiomas usually appear within the first weeks of life and grow most rapidly during the first three to six months of life. For most hemangiomas, 80% of infantile hemangioma size is generally reached by 3 months of age. Usually, growth and proliferation is complete and involution commences by twelve months of age. However, involution occurs slowly over many years with a majority of infantile hemangioma regression occurring by five years of age. Although infantile hemangiomas spontaneously regress over time, some may leave residual redundant fibrofatty tissue, scar, residual telangiectasia, or pigmentary changes. The word "hemangioma" comes from the Greek haema- (αίμα), "blood"; angeio (αγγείο), "vessel"; -oma (-ωμα), "tumor".

تحديث لأحدث إصدار 1.0.0

Last updated on 09/04/2018

Minor bug fixes and improvements. Install or update to the newest version to check it out!

جاري في الترجمة...

معلومات أكثر ل تطبيق

احدث اصدار

طلب Hemangioma Disease تحديث 1.0.0

محمل

Carlo Sabale

Android متطلبات النظام

Android 4.1+

عرض المزيد

Hemangioma Disease لقطات الشاشة

اللغات
اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
تم الاشتراك بنجاح!
أنت مشترك الآن في APKPure.
اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
نجاح!
لقد اشتركت في أخبار لدينا الآن لدينا.